Reversal of multidrug resistance by novel nitrophenyl pyrones, SNF4435C and D

Japanese Journal of Cancer Research

Volumn 92, Issue 11, 2001, Pages 1235-1241

  Kurosawa, Kazuhiko ^a   Takahashi, Kosaku ^a   Tsuda, Eisuke ^a   Tomida, Akihiro ^b   Tsuruo, Takashi ^b,c  

^a SNOW BRAND MILK PRODUCTS CO LTD   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c CANCER CHEMOTHERAPY CENTER   (Japan)

Author keywords

MDR modifier; Multidrug resistance (MDR); P glycoprotein; SNF4435C; SNF4435D

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOSPORIN A; DOXORUBICIN; GLYCOPROTEIN P; IMMUNOSUPPRESSIVE AGENT; PYRONE DERIVATIVE; SNF 4435C; SNF 4435D; TACROLIMUS; UNCLASSIFIED DRUG; VERAPAMIL; VINCRISTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOACCUMULATION; CANCER CHEMOTHERAPY; CELL STRAIN K 562; CONTROLLED STUDY; DRUG EFFICACY; DRUG SENSITIVITY; DRUG STRUCTURE; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA P 388; MOUSE; MULTIDRUG RESISTANCE; MYELOID LEUKEMIA; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; STREPTOMYCES; TUMOR CELL;

EID: 0035206547     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2001.tb02145.x     Document Type: Article

References (24)

1. Expression of a multidrug resistance gene in human cancers
2. The role of the MDR1 (P-glycoprotein) gene in multidrug resistance in vitro and in vivo
3. P-Glycoprotein-a mediator of multidrug resistance in tumor cells
4. Mechanisms of multidrug resistance and implications for therapy
5. The biochemistry of P-glycoprotein-mediated multidrug resistance
6. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil
7. Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors
8. Phase I study of intravenous PSC-833 and doxorubicin: Reversal of multidrug resistance
9. A new quinoline derivative MS-209 reverses multidrug resistance and inhibits multiorgan metastases by P-glycoprotein-expressing human small cell lung cancer cells
10. Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979
11. New taxanes as highly efficient reversal agents for multi-drug resistance in cancer cells
12. Reversal of anticancer multidrug resistance by the ardeemins
13. Multidrug resistance reversal activity of taxoids from Taxus cuspidata in KB-C2 and 2780AD cells
14. SNF4435C and D, novel immunosuppressants produced by a strain of Streptomyces spectabilis. I. Taxonomy, fermentation, isolation and biological activities
15. SNF4435C and D, novel immunosuppressants produced by a strain of Streptomyces spectabilis. II. Structure elucidation
16. Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro
17. Reversal of multidrug resistance by an immunosuppressive agent FK-506
18. Characteristics of vincristine resistance in vincristine resistant human myelogenous leukemia K562
19. Characteristics of resistance to adriamycin in human myelogenous leukemia K562 resistant to adriamycin and in isolated clones
20. Reversal of adriamycin resistance by verapamil in human ovarian cancer
21. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
22. Biochemistry of multidrug resistance mediated by the multidrug transporter
23. P-Glycoprotein, multidrug resistance and tumor progression
24. Cyclosporins as drug resistance modifiers